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Mammalian spermatogenesis is an elaborately organized differenti-
ation process, starting with diploid spermatogonia, which include
germ-line stem cells, and ending with haploid spermatozoa. The
process involves four pivotal transitions occurring in physical prox-
imity: spermatogonial differentiation, meiotic initiation, initiation of
spermatid elongation, and release of spermatozoa. We report how
the four transitions are coordinated in mice. Two premeiotic transi-
tions, spermatogonial differentiation and meiotic initiation, were
known to be coregulated by an extrinsic signal, retinoic acid (RA). Our
chemical manipulations of RA levels in mouse testes now reveal
that RA also regulates the two postmeiotic transitions: initiation of
spermatid elongation and spermatozoa release. We measured RA
concentrations and found that they changed periodically, as also
reflected in the expression patterns of an RA-responsive gene, STRA8;
RA levels were low before the four transitions, increased when the
transitions occurred, and remained elevated thereafter. We found
that pachytene spermatocytes, which express an RA-synthesizing
enzyme, Aldh1a2, contribute directly and significantly to RA produc-
tion in testes. Indeed, chemical and genetic depletion of pachytene
spermatocytes revealed that RA from pachytene spermatocytes was
required for the two postmeiotic transitions, but not for the two
premeiotic transitions. We conclude that the premeiotic transitions
are coordinated by RA from Sertoli (somatic) cells. Once germ cells
enter meiosis, pachytene spermatocytes produce RA to coordinate
the two postmeiotic transitions. In combination, these elements un-
derpin the spatiotemporal coordination of spermatogenesis and en-
sure its prodigious output in adult males.
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Mammalian spermatogenesis is a choreographed process inwhich diploid spermatogonia undergo differentiation to
give rise to specialized haploid gametes, called spermatozoa.
Within the testis, several key developmental transitions of
spermatogenesis occur in close physical and temporal proximity.
These transitions must be carefully regulated to ensure that large
numbers of spermatozoa are produced continuously throughout
reproductive life. We address the question of how these transi-
tions are coordinated at the cellular and molecular level.
During spermatogenesis, four key transitions stand out: (i) dif-
ferentiation of spermatogonia, (ii) meiotic initiation, (iii) initiation
of spermatid elongation, and (iv) release of spermatozoa into the
lumen of seminiferous tubules (Fig. 1). In mice, spermatogenesis
begins with undifferentiated type A spermatogonia, which include
the stem cells (1–4). Undifferentiated spermatogonia periodically
undergo spermatogonial differentiation (also known as the Aaligned-
to-A1 transition) to become differentiating spermatogonia (also
known as A1/A2/A3/A4/intermediate/B spermatogonia). During
spermatogonial differentiation, the spermatogonia lose the capac-
ity for self-renewal (5) and begin a series of six transit-amplifying
mitotic divisions (6). Germ cells then become spermatocytes and
undergo meiotic initiation (7, 8). DNA replication and two cell
divisions follow, resulting in the formation of haploid, round
spermatids, which elongate their nuclear and cytoplasmic contours
to become spermatozoa. Finally, these spermatozoa are released
into the lumen of seminiferous tubules.
The four key transitions of spermatogenesis are precisely co-
ordinated in time and space and occur in close physical and tem-
poral proximity, cyclically, with an 8.6-d periodicity in mice (9). The
mouse testis is composed of structures known as seminiferous tu-
bules (Fig. S1A); within tubule cross-sections, one sees stereotypical
collections or associations of germ cells at various steps of differ-
entiation (Fig. 1). The precise coordination of these steps is called
the “cycle of the seminiferous epithelium” (or “seminiferous cy-
cle”). In mice, researchers have characterized 12 distinct cellular
associations, known as seminiferous stages I to XII (10); the four
key transitions all occur in stages VII and VIII (10, 11) (Fig. 1 and
Fig. S1 B–D). This intimate proximity of the four transitions to each
other is largely conserved in other mammals, including humans
(12), rats (13, 14), hamsters (15), and rams (15). The layered gen-
erations of germ cells in the seminiferous tubule are embedded in
and supported by somatic (Sertoli) cells that supply factors essential
for spermatogenesis (16). We sought to investigate the cooccur-
rence of the four key transitions, to understand the regulation of
these transitions and the overall organization of spermatogenesis.
Both of the premeiotic transitions—spermatogonial differentia-
tion and meiotic initiation—require retinoic acid (RA), a derivative
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of vitamin A. In vitamin A-deficient (VAD) mice and rats, most
germ cells arrest as undifferentiated spermatogonia (17, 18). In
VAD rat testes, some germ cells also arrest just before meiosis, as
preleptotene spermatocytes (19). When VAD animals are given RA
or vitamin A, the arrested spermatogonia differentiate (17–19), and
the arrested preleptotene spermatocytes initiate meiosis (19).
Moreover, deficiency of the RA target gene Stimulated by retinoic
acid gene 8 (Stra8), which is expressed exclusively in germ cells (20,
21), causes the failure of meiotic initiation and accumulation of
undifferentiated spermatogonia (7, 8, 22). Using Stra8 as an RA-
responsive marker to predict RA levels, we previously reported that
rising RA levels coordinate the two premeiotic transitions (22).
Given that the two postmeiotic transitions—initiation of sper-
matid elongation and release of spermatozoa—coincide with high
RA levels, we considered the possibility that RA might also reg-
ulate these two transitions. Indeed, ablations of RA receptors
(RARs) or RA-synthesizing enzymes (in germ cells and/or Sertoli
cells) cause a variety of modest defects in meiotic and postmeiotic
aspects of spermatogenesis, including release of spermatozoa (23–
29). Nonetheless, the specific steps in meiotic progression or
postmeiotic differentiation that RA might regulate have not been
established. Moreover, the identity of the cells that supply the RA
responsible for premeiotic and/or postmeiotic transitions remains
unclear. To explore these questions empirically, we reasoned that
we would also need to measure the absolute concentration of RA
in testes under a range of experimental conditions.
We first chemically manipulated RA levels in living testes and
examined the effects on the two postmeiotic transitions. We then
investigated the timing and magnitude of changes in testicular
RA concentration by absolute quantification, and we explored
which cells provide the RA responsible for these four transitions
by genetic and chemical cell depletion assays. We conclude that
the two postmeiotic transitions are coordinated by RA produced
by pachytene spermatocytes while the two premeiotic transitions
are coordinated by RA produced by Sertoli cells.
Results
RA Induces Release of Spermatozoa. We chemically manipulated
RA levels in living testes to probe whether RA induces the release
of spermatozoa. To ensure the efficacy of our experimental pro-
tocols, we first confirmed that i.p. injection of exogenous RA raises
the concentration of RA in testes, and, conversely, that injection of
WIN18,446, an inhibitor of RA synthesis (30), lowers RA levels in
testes. We monitored RA levels in testes both indirectly, by
immunostaining for STRA8 as an RA-responsive marker (20, 31,
32), and directly, by measuring RA levels via liquid chromatog-
raphy/mass spectrometry (LC/MS). In control testis sections,
STRA8 protein was not detectable in germ cells in seminiferous
stages V and VI (before key transitions) but was clearly present in
spermatogonia and preleptotene spermatocytes in stages VII and
VIII (during key transitions) (22) (Fig. S2A). As expected, at 1 d
after a single RA injection, STRA8 was strongly induced in stages
V and VI. Conversely, after 2 d of daily WIN18,446 injections,
STRA8 was not expressed in stages VII and VIII. LC/MS assays
confirmed that RA concentrations in testes were markedly in-
creased 1 d after RA injection and markedly decreased after 2 or
4 d of daily WIN18,446 injection (Fig. 2A).
In the unperturbed testis, spermatozoa are released in late stage
VIII (Fig. 1). If RA induces this release, then WIN18,446 injection
should increase the percentage of seminiferous tubules that con-
tain aligned spermatozoa, which are located along the luminal
edge of the seminiferous tubules and are awaiting release into the
lumen (Fig. S1D). Indeed, this is what we observed: After 2 or 4 d
of daily WIN18,446 injection, the percentage of tubule cross-
sections containing aligned spermatozoa was increased (Fig. 2
B–D, Fig. S2 B–E, and SI Results); release of spermatozoa was
inhibited not only in late stage VIII but also in stages IX and X
(Fig. 2E and Fig. S2F). If this inhibition of spermatozoa release is
a consequence of RA depletion, then injection of RA might be
expected to induce premature release of spermatozoa. Indeed, at
2 d after a single RA injection, the percentage of tubules con-
taining aligned spermatozoa was decreased, particularly in stage
VIII (Fig. 2 B–D and Fig. S2 B–E). We conclude that RA induces
the release of spermatozoa.
RA Promotes Initiation of Spermatid Elongation. We then tested
whether RA also affects spermatid elongation, the other key post-
meiotic transition (Fig. 1). In the unperturbed testis, spermatid
development has been subdivided into 16 steps; step 8 round
spermatids initiate their elongation in stage VIII and become step
9 elongating spermatids in stage IX (Fig. 1). If RA induces this
initiation of spermatid elongation, thenWIN18,446 injection should
increase the percentage of seminiferous tubules that contain step
7 and 8 round spermatids. Indeed, following 2 or 4 d of daily
WIN18,446 injection, the percentage of tubules containing step
7 and 8 round spermatids was increased, and the percentage of
tubules containing step 9 and 10 elongating spermatids was corre-
spondingly decreased (Fig. 3 A and B). Extending these daily in-
jections to 21 d resulted in a nearly complete arrest at step 7 and
8 round spermatids (Fig. S3A and SI Results). By contrast, at 2 d
after a single RA injection, the percentage of tubules containing
step 7 and 8 round spermatids was decreased, and the percentage of
tubules containing step 9 and 10 elongating spermatids was corre-
spondingly increased (Fig. 3 A and B). These quantitative results
indicate that initiation of spermatid elongation is regulated by RA.
We next used pulse–chase labeling (33, 34) to confirm that RA
causes spermatid elongation to be initiated earlier than it would
normally occur. When a single BrdU injection is given, BrdU is
incorporated into cells in mitotic or premeiotic S phase. At 4 h after
BrdU injection, the most advanced BrdU-labeled germ cells are
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Fig. 1. Diagram of mouse spermatogenesis. Oakberg (10) identified 12 distinct
cellular associations, called seminiferous stages I to XII. It takes 8.6 d for a section
of seminiferous tubule, and the germ cells contained within, to cycle through all
12 stages (9). Four turns of this seminiferous cycle are required for a germ cell to
progress from undifferentiated spermatogonium to spermatozoon ready to be
released into tubule lumen. Adiff, differentiating type A spermatogonia; Aundiff,
undifferentiated type A spermatogonia; B, type B spermatogonia; D, diplotene
spermatocytes; In, intermediate spermatogonia; L, leptotene spermatocytes; P,
pachytene spermatocytes; Pl, preleptotene spermatocytes; SC2, secondary
spermatocytes; Z, zygotene spermatocytes. Steps 1 to 16, steps in spermatid
differentiation. Purple, germ cells undergoing spermatogonial differentiation;
green, meiotic initiation; brown, initiation of spermatid elongation; gray, re-
lease of spermatozoa. Adapted from refs. 22 and 62.
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preleptotene spermatocytes that have undertaken premeiotic S and
thereby initiated the meiotic program (Fig. S3 B and C). In the
unperturbed testis, these BrdU-labeled preleptotene spermatocytes
develop into step 8 round and step 9 and 10 elongating spermatids,
respectively, 17.2 and 18.2 d after BrdU injection (Fig. 3C). We
predicted that RA or WIN18,446 treatment would accelerate or
delay spermatid development, respectively, at 18.2 d after the BrdU
labeling, when the most advanced BrdU-labeled germ cells in un-
perturbed testes have initiated spermatid elongation. To test this,
we gave mice a single BrdU injection, followed by daily RA or
WIN18,446 injection during spermatid development (Fig. 3C), and
harvested the testes at 17.2 d (Exps. 1 to 3) or 18.2 d (Exps. 4 to 6).
We found that, at 17.2 d after BrdU injection, the most advanced
BrdU-labeled germ cells were step 8 round spermatids in control
testes, and there was no acceleration or delay under RA or
WIN18,446 treatment (Fig. S3 D and F). This demonstrates that
RA does not affect the development of round spermatids, from step
1 to step 8. However, as predicted, at 18.2 d after BrdU injection,
the most advanced BrdU-labeled germ cells, which were step 10
spermatids in controls, had developed further—into step 11
spermatids—in RA-treated testes whereas they were still step
9 spermatids in WIN18,446-treated testes (Fig. 3D and Fig. S3F).
Taken together, these findings provide strong evidence that RA
promotes the initiation of spermatid elongation.
RA Has No Discernible Effect on Meiotic Progression.Given that four
of the five generations of spermatogenic cells undergo transitions
coregulated by RA in stages VII and VIII (Fig. 1), we wondered
whether the remaining cell type at these stages, pachytene
spermatocytes, also undergoes RA-regulated development dur-
ing meiotic progression.
We examined this possibility by pulse–chase labeling. We gave
mice a single injection of BrdU, followed by daily RA or
WIN18,446 injection during meiotic progression (Fig. 3C, Exps.
7 to 9), and harvested the testes at 12.6 d, when, in control testes,
the most advanced BrdU-labeled germ cells have completed mei-
otic progression and become step 1 and 2 spermatids. At 12.6 d,
there was no acceleration or delay under RA or WIN18,446
treatment (Fig. S3 E and F). These results indicate that RA does
not affect meiotic progression as assayed histologically.
To verify that RA does not affect meiotic progression at the
molecular level, we tested for key molecular features of meiotic
progression by immunohistochemistry. We first gave mice a single
injection of 5-ethynyl-2′-deoxyuridine (EdU), followed by daily RA
or WIN18,446 injection during meiotic progression (Fig. 4A), and
harvested testes at 8.6 d (Exps. 10 to 12) and 11 d (Exps. 13 to 15),
when in control testes the most advanced EdU-labeled germ cells
have progressed to late pachytene stage and diplotene stage, re-
spectively (35). We then immunostained the EdU-labeled nuclear
spreads of spermatocytes for markers of meiotic prophase to dis-
tinguish among middle pachytene, late pachytene, and diplotene
stages. Specifically, we used antibodies against phosphorylated
H2A histone family member X (γH2AX) (a marker of DNA
double strand breaks and sex body formation) (36), synaptonemal
complex protein 3 (SYCP3) (a marker of synaptonemal complex)
(37), testis-specific histone (H1t) (a marker of middle/late pachy-
tene stages) (38), and ataxia telangiectasia and Rad3-related
protein (ATR) (a marker of DNA repair and sex body forma-
tion) (39). Based on these markers (SI Results), at 8.6 d and 11 d
after EdU injection, the most advanced EdU-labeled germ cells in
control testes were, respectively, late pachytene and diplotene
spermatocytes, and there was no acceleration or delay after RA or
WIN18,446 treatment (Fig. 4 B–D and Fig. S4). Importantly, ex-
pression and localization of all of the meiotic markers appeared to
be unaffected by either RA orWIN18,446 treatment. We conclude
that RA has no discernible effect on meiotic progression from
leptotene stage to diplotene stage, including the development of
pachytene spermatocytes.
Our results demonstrate that RA regulates release of sper-
matozoa and initiation of spermatid elongation, as well as sper-
matogonial differentiation and meiotic initiation, but not meiotic
progression, in stages VII and VIII. To explore the mecha-
nism by which these four transitions are coordinated in time and
space by RA, we next focused on changes in RA levels in the
seminiferous tubules.
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Fig. 2. RA induces release of spermatozoa. (A) Absolute quantification of RA concentrations (pmol/g of testes) in control and RA-injected and WIN18,446-
injected adult testes. Mice were given a single dose of RA or daily injections of WIN18,446 for 2 or 4 d. Dashed line, limit of detection. ND, not detected (below
limit of detection). Bar graphs after RA or WIN18,446 treatment show results of two biological replicates. Error bars, mean ± SD, *P < 0.05, **P < 0.01,
compared with control (one-tailed t test). (B) Percentage of testis tubule cross-sections containing aligned spermatozoa, in controls, or 2 d after single RA
injection, or after 2 or 4 d of daily WIN18,446 (WIN) injection. Error bars, mean ± SD, *P < 0.05, **P < 0.01, compared with control (one-tailed t test). (C and D)
Number of stage VIII (C) or stage IX (D) tubule cross-sections with aligned spermatozoa per total stage VIII (C) or stage IX (D) tubule cross-sections, in controls,
or 2 d after single RA injection, or after 2 or 4 d of daily WIN18,446 injection. Error bars, mean ± SD, *P < 0.05, **P < 0.01, compared with control (one-tailed
t test). (E) Control (Top) and WIN18,446-injected (Bottom) testis cross-sections in early stage VIII (Left), late stage VIII (Middle), and stage IX (Right), stained
with hematoxylin and periodic acid-Schiff (He-PAS). Insets (65.5 μm × 65.5 μm) enlarge boxed regions. (Scale bar: 30 μm.)
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RA Concentrations Change Periodically, as Reflected by STRA8 Expression
Patterns. We previously reported that STRA8, an RA responsive
marker, is expressed periodically in the unperturbed testis:
Expression of the protein is low or absent in spermatogonia in
stages II to VI, increased in stages VII and VIII, and remains high in
stages IX to I (22). Thus, we postulated that the STRA8 expression
patterns reflect periodic changes in RA levels: RA levels might rise in
stages VII and VIII, to coordinate the four transitions, and remain
high until stages XII/I. To test these predictions, we quantified RA
concentrations in seminiferous stage-synchronized testes by LC/MS.
In unperturbed mouse testes, the seminiferous stages of the
tubules are not synchronized across the testis but instead are
highly diverse (40) (Fig. S1B). When mice are treated daily with
WIN18,446 from postnatal day 2 (P2), germ cells arrest as un-
differentiated spermatogonia at stages VII and VIII (41) (Fig. 1).
After a single injection of RA into these WIN18,446-pretreated
mice, the arrested germ cells undergo spermatogonial differenti-
ation to initiate spermatogenesis in a synchronized manner (41).
Thus, we gave daily injections of WIN18,446 from P2 until P14
(Fig. S5A and SI Results) and then injected a single dose of RA at
P15, harvesting testes 5, 8, 9, or 10 d after the RA injection (Fig.
5A and Fig. S5B). As we anticipated, at 5 d after RA injection,
when seminiferous tubules were synchronized at stages II to IV,
the RA concentration was negligible or very low (Fig. 5B and Fig.
S5D). Then, at 8 d, in stages VII to IX, the RA concentration was
significantly increased, and it remained high at 9 d, in stages IX to
XI, before falling modestly at 10 d, in stages XI to I (difference
between RA levels in stages VII to IX and XI to I is not signifi-
cant; P > 0.05, Tukey–Kramer test). We conclude that RA con-
centrations change periodically, as also reflected by, and in good
agreement with, STRA8 expression patterns (Fig. S5C).
RA Concentration Increases When Aldh1a2-Expressing Pachytene
Spermatocytes First Appear. We then considered the identity of the
cells within the seminiferous tubules that produce RA. Sertoli cells,
which have been shown to express an RA-synthesizing enzyme, al-
dehyde dehydrogenase 1A1 (Aldh1a1) (42, 43), are likely the source
of the RAmeasured in the experiments just described. Another RA-
synthesizing enzyme, Aldh1a2, is abundantly expressed in pachytene
spermatocytes (and their descendants, diplotene spermatocytes)
from stages VII through XII (42, 43). If pachytene spermatocytes
actually produce RA from stage VII onward, then RA levels in the
testes of young males should rise shortly after these Aldh1a2-
expressing pachytene cells first appear (at about 15 d after RA-
induced spermatogonial differentiation). To test this prediction, we
harvested stage-synchronized testes at 12, 15, 16, and 17 d after RA
injection, when pachytene and then diplotene spermatocytes first
appear (Fig. 5A and Fig. S5B), for absolute quantification of RA
levels. At 12 d after RA injection, when seminiferous tubules con-
taining pachytene spermatocytes were in stages II to IV, RA con-
centration was very low, similar to 5 d after RA injection (Fig. 5B
and Fig. S5D). As predicted, at 15 d after RA injection, in stages VII
to IX, RA concentration was increased and significantly higher than
at 8 d, when pachytene spermatocytes were not yet present. The
higher RA concentration was maintained at 16 d and 17 d, in stages
IX to XI and stages XI to I, respectively. The simplest interpretation
of these data is that pachytene spermatocytes not only express
Aldh1a2 but also produce RA from stages VII and VIII onward.
Depletion of Pachytene Spermatocytes Reduces RA Concentration in
Adult Testes. Building upon these findings, we hypothesized that
RA produced by pachytene spermatocytes might induce or con-
tribute to some of the key germ cell transitions that occur in stage
VII and VIII tubules (Fig. 1). To explore the functional roles of
RA produced by pachytene spermatocytes, we conditionally re-
moved pachytene spermatocytes from adult testes, using a cell
depletion assay. Hydroxyurea (HU) specifically inhibits the ribo-
nucleotide reductase that generates deoxyribonucleotides required
for DNA replication, by binding the enzyme’s iron molecules,
thereby killing cells that are in S phase (44, 45). We injected adult
mice with HU six times, at 6-h intervals, and we first assessed the
results of HU treatment at 36 h (1.5 d) after the initial injection.
As expected, all differentiating spermatogonia (A1/A2/A3/A4/
intermediate/B spermatogonia) and stage VII preleptotene sper-
matocytes had been eliminated by HU treatment (Fig. 5C, Fig.
S6A, and SI Results), with no cytotoxic effects on the remaining
germ cells, or on Sertoli cells (46). At 11.6 d after the first HU
injection, the specific cohort of germ cells that normally would
have transited to pachytene and diplotene in stages I to XII was
missing from the testis, as expected (Fig. 5C and Fig. S6B); in
stage VII and VIII tubules, pachytene spermatocytes were the
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Fig. 3. RA promotes initiation of spermatid elongation. (A and B) Per-
centage of testis tubule cross-sections containing step 7 and 8 (A) or step
9 and 10 (B) spermatids, in controls, or 2 d after single RA injection, or after
2 or 4 d of daily WIN18,446 injection. Error bars, mean ± SD, *P < 0.05, **P <
0.01, compared with control (one-tailed t test). (C) Diagram of predicted
development of most advanced BrdU-labeled germ cells following single
BrdU injection. Mice received daily injections of RA or WIN18,446 until the
observation points, when testes were harvested (Exps. 1 to 9). D, diplotene
spermatocytes; L, leptotene spermatocytes; P, pachytene spermatocytes; Pl,
preleptotene spermatocytes; Z, zygotene spermatocytes. St1-2, St8, and St9–
10: steps in spermatid differentiation. (D) The most advanced BrdU-labeled
germ cells in testis cross-sections of control (Left), RA-injected (Middle), or
WIN18,446-injected (Right) mice 18.2 d (Exps. 4 to 6) after single BrdU in-
jection, immunostained for BrdU with hematoxylin and periodic acid-Schiff
(He-PAS) staining. Insets (7.5 μm × 7.5 μm) enlarge boxed regions. Arrows:
step 9 (red), step 10 (black), step 11 (blue) spermatids. (Scale bar: 10 μm.)
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only missing cells, again as expected (Fig. 5D and Fig. S6C). Im-
portantly, testicular RA concentrations were significantly lower
than in controls (Fig. 5E and Fig. S6 D and E). Also, as predicted,
we observed that the remaining levels of RA, which probably
derived from Sertoli cells, were eliminated by coinjection of
WIN18,446 with HU. We conclude that conditional depletion of
pachytene spermatocytes reduces RA levels in adult testes.
To confirm that the reduced RA concentration at 11.6 d after
the first HU injection was associated with the depletion of a
specific RA-synthesizing enzyme from seminiferous tubules, we
carried out single-molecule fluorescence in situ hybridization
(smFISH). Because smFISH probes detect and localize each target
mRNA molecule as a punctate signal, these signals can be quan-
tified to determine the number of transcripts per cell (47) (SI Re-
sults). In control stage VII and VIII tubules, Aldh1a2 was expressed
specifically in pachytene spermatocytes, Aldh1a1 was expressed
specifically in Sertoli cells, and Aldh1a3 was expressed at very low
levels, if at all, in germ cells and Sertoli cells (Fig. 6), all as pre-
viously reported (42, 43); we used kidney as a positive control for
Aldh1a3 (Fig. S7 E and F and SI Results). As predicted, at 11.6 d
after the first HU injection, Aldh1a2 transcripts were dramatically
reduced in seminiferous tubules, likely because of the absence of
pachytene spermatocytes. Importantly, we observed no compen-
satory up-regulation of Aldh1a1, Aldh1a2, or Aldh1a3 in the
remaining germ or Sertoli cells of the seminiferous tubules, despite
the fact that such compensation has been observed to accompany
genetic ablation of these genes in other contexts (48, 49). Con-
versely, HU depletion of pachytene spermatocytes did not result in
reduced expression of Aldh1a1, Aldh1a2, or Aldh1a3 in the
remaining germ or Sertoli cells. Thus, the reduction in RA con-
centration upon depletion of pachytene spermatocytes was not due
to reduced expression of RA-synthesizing enzymes in the remaining
cells of the seminiferous tubules. Instead, depletion of ALDH1A2-
expressing pachytene spermatocytes reduces testicular RA con-
centrations directly. We then proceeded to test whether RA from
pachytene spermatocytes contributes functionally to the four key
transitions in stages VII and VIII, using HU-treated testes.
RA from Pachytene Spermatocytes Is Required for Postmeiotic, but
Not for Premeiotic, Transitions. If RA from pachytene spermato-
cytes is required for release of spermatozoa and initiation of
spermatid elongation, seminiferous tubules should display accu-
mulations of aligned (unreleased) spermatozoa and round
(unelongated) spermatids, respectively, at 11.6 d after the first HU
injection. Indeed, at 11.6 d after the first HU injection, seminif-
erous tubules displayed increased numbers of aligned spermato-
zoa and step 7 and 8 round spermatids (Fig. 7 A and B and Fig. S8
A–D). These accumulations of unreleased spermatozoa and un-
elongated spermatids in response to HU were not exacerbated by
coinjecting WIN18,446 with HU. Moreover, when a single dose of
RA was injected 9.6 d after the first HU injection, the abnormal
accumulations were cured, or rescued, at 11.6 d, indicating that
the accumulations after pachytene spermatocyte depletion were
due specifically to the resulting decrease in RA concentration. We
conclude that RA from pachytene spermatocytes is required for
initiation of spermatid elongation and for release of spermatozoa.
We next tested whether RA from pachytene spermatocytes is re-
quired for meiotic initiation. At 11.6 d after the first HU injection,
both preleptotene spermatocytes and type A spermatogonia in stages
VII and VIII expressed Stra8 (transcripts) at levels similar to those of
A
B
C
D
Fig. 4. RA has no discernible effect on meiotic pro-
gression after entry into meiotic prophase. (A) Dia-
gram of predicted development of most advanced
EdU-labeled germ cells following single EdU in-
jection. Mice received daily injections of RA or
WIN18,446 until the observation point, when testes
were harvested (Exps. 10 to 15). D, diplotene sper-
matocytes; eP, early pachytene spermatocytes; L,
leptotene spermatocytes; lP, late pachytene sper-
matocytes; mP, mid pachytene spermatocytes; Pl,
preleptotene spermatocytes; Z, zygotene spermato-
cytes. (B and C) The most advanced EdU-labeled
germ cells in nuclear spreads of spermatocytes in
control or daily RA- or WIN18,446-injected mice at
8.6 d (B; Exps. 10 to 12; late pachytene stage) or 11 d
(C; Exps. 13 to 15; diplotene stage) after a single EdU
injection, immunostained for SYCP3 (green), γH2AX
(red), and EdU (blue). (B, Far Left ) Representative
mid-pachytene spermatocyte showing no EdU signal
in controls. (Scale bars: 10 μm.) (D) Numbers and
percentages of mid-pachytene, late pachytene, and
diplotene cells positive for EdU. Percentages of EdU+
cells did not differ significantly among control, RA-
treated, and WIN-treated groups (three biological
replicates; P > 0.05; χ2 test).
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controls (Fig. 6A and Fig. S7D), suggesting that these germ cells are
responding normally, to endogenous RA, even in the absence of
pachytene spermatocytes and the RA that they provide. If RA from
pachytene cells is not required for meiotic initiation, then premeiotic
or early meiotic (leptotene) spermatocytes should not be increased or
decreased after pachytene spermatocyte depletion. Indeed, at 11.6 d
after the first HU injection, there was no increase in the numbers of
tubules containing premeiotic (preleptotene) spermatocytes or de-
crease in the numbers of tubules containing early meiotic (leptotene)
spermatocytes (Fig. 7C and Fig. S8 A, B, E, and F). Similarly, we
confirmed that genetic depletion of pachytene spermatocytes, in
Dmc1- or Spo11-deficient mice, had no discernible effect on pre-
leptotene or leptotene spermatocytes; in these mutant mice, defects
in meiotic progression result in apoptosis of pachytene spermatocytes
before or during stage IV (50–53). By contrast, coinjection of
WIN18,446 with HU did increase preleptotene spermatocytes and
decrease leptotene spermatocytes, and coinjection of RA with HU
decreased preleptotene spermatocytes and increased leptotene
spermatocytes. These results suggest that meiotic initiation re-
quires RA from sources other than pachytene spermatocytes.
Finally, we tested whether RA from pachytene spermatocytes is
required for spermatogonial differentiation, by immunostaining for
functional markers of spermatogonial differentiation, STRA8 and
KIT (22, 54). As mentioned above, at 11.6 d after the first HU in-
jection, type A spermatogonia in stages VII and VIII expressed Stra8
(transcripts) at levels like those seen in controls (Fig. 6A and Fig.
S7D). Similarly, we found that expression of the STRA8 and KIT
proteins in spermatogonia was unaffected in stages VII and VIII at
11.6 d after the first HU injection (Fig. 7D). By contrast, STRA8 and
KIT were not expressed in these cells following coinjection of
WIN18,446 with HU, suggesting that spermatogonial differentiation
also requires RA from sources other than pachytene spermatocytes.
We conclude that RA from pachytene spermatocytes is required for
initiation of spermatid elongation and release of spermatozoa, but
not for spermatogonial differentiation or meiotic initiation (Fig. 8).
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Fig. 5. RA concentrations change periodically, and RA
derives in part from pachytene spermatocytes. (A) Di-
agram of synchronous germ cell development after
RA-induced spermatogonial differentiation in WIN18,446-
pretreated young mice. Mice were given daily injec-
tions of WIN18,446 from postnatal day 2 (P2) until
P14 and were then given a single dose of RA at P15.
Testes were harvested at the indicated days after the
RA injection. Blue, high Aldh1a2 expression (43). Adiff,
differentiating type A spermatogonia; Aundiff, undif-
ferentiated type A spermatogonia; B, type B spermato-
gonia; D, diplotene spermatocytes; In, intermediate
spermatogonia; L, leptotene spermatocytes; P, pachy-
tene spermatocytes; Pl, preleptotene spermatocytes;
Z, zygotene spermatocytes. St1, step 1 spermatids.
(B) Absolute quantification of RA levels (pmol/g
of testes) in synchronized (WIN18,446/RA-injected)
young testes. Bar graphs at 12, 15, 16, and 17 d after
RA injection show results of two biological repli-
cates. Error bars, mean ± SD, *P < 0.05 (one-tailed
t test). (C) Germ cell depletion after hydroxyurea
(HU) injection. Mice received six injections of HU at
6-h intervals. Boxes, completely depleted germ cell
cohort 1.5 d (green) or 11.6 d (orange) after first HU
injection. (D) Testis cross-sections in stages VII and
VIII of control (Left) or HU-injected (Right) mice,
stained with hematoxylin and periodic acid-Schiff
(He-PAS). Orange dots, pachytene spermatocytes.
(Scale bar: 30 μm.) (E ) Quantification of RA levels
(pmol/g of testes) in testes of control and HU-injected
adult mice. HU + WIN, mice were given injections of
HU and then daily injections of WIN18,446, beginning
7.6 d after first HU injection. WIN, mice received daily
injections of WIN18,446 for 4 d. Dashed line, limit of
detection. ND, not detected (below limit of detection).
The far right “WIN” bar graph shows results of two
biological replicates. Error bars, mean ± SD, *P < 0.01
(Tukey–Kramer test).
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Discussion
RA Regulates Four Key Transitions of Spermatogenesis.We investigated
the chemical basis of the exquisite coordination of spermato-
genesis, the process by which diploid spermatogonia differentiate
into specialized haploid gametes, spermatozoa, at a constant
rate. We found that rising levels of an extrinsic signal, RA, reg-
ulate four key developmental transitions in mouse spermato-
genesis: spermatogonial differentiation and meiotic initiation
before meiosis (22) and initiation of spermatid elongation and
release of spermatozoa after meiosis (Fig. 8A). We also found
that these pre- and postmeiotic transitions require RA from
different cell sources: Sertoli (somatic) cells and pachytene
spermatocytes (meiotic cells), respectively (Fig. 8B). We will now
discuss the implications of these findings for understanding the
regulation of this temporally and spatially coordinated system of
cell division and differentiation (10, 14).
By chemically manipulating the levels of RA in the testes of live
animals, we found that RA plays critical, primary roles in the two
postmeiotic transitions: initiation of spermatid elongation and re-
lease of spermatozoa. Indeed, both of these transitions were
inhibited within 2 d after starting injections of a potent inhibitor of
RA synthesis, WIN18,446. Conversely, injection of RA was suffi-
cient to induce both of these postmeiotic transitions, again within
2 d. These findings align with, and help explain, prior reports of
postmeiotic defects caused by genetic or chemical ablation of RA
receptors (RARs) or RA-synthesizing enzymes (23–29). Further,
we found that, after meiotic initiation, progression and completion
of meiosis and subsequent development of round spermatids are
unaffected by manipulations of RA levels, suggesting that RA plays
little or no direct role in this middle, 17-d stretch of spermato-
genesis. Because RA also coregulates the two premeiotic transitions
(17–19, 22), our present findings demonstrate that four of the five
generations of spermatogenic cells present in stage VII and VIII
tubules undergo transitions regulated by a single extrinsic cue, RA.
It remains to be determined whether RA acts directly on germ cells
or indirectly, via Sertoli cells, to regulate the two postmeiotic transi-
tions. RA serves as a ligand to nuclear receptors known as RARs and
retinoid X receptors (RXRs), which bind to RA response elements
(RAREs) in the regulatory regions of target genes (55). These re-
ceptors are expressed specifically in round spermatids in stages VII
and VIII (during key transitions) (42), suggesting that RA acts di-
rectly on round spermatids to induce their elongation. Indirect RA
signaling, via RARs/RXRs in Sertoli cells (42), may also contribute to
A B
C
D
Fig. 6. Depletion of pachytene spermatocytes re-
duces Aldh1a2 expression in seminiferous tubules.
(A) Single-molecule fluorescence in situ hybridization
(smFISH) for mRNAs of Aldh1a1 (green), Aldh1a2
(green), Aldh1a3 (green), and Stra8 (red), with DAPI
counterstain (gray), on testis cross-sections in stages
VII and VIII of control and HU-injected mice. Single
transcripts are visible as punctate signals. Large spots
in round spermatids are nonspecific signals (SI Re-
sults). Yellow spots in merged images are auto-
fluorescent signals. Boxed regions (32.5 μm × 32.5 μm)
in DAPI images (65 μm × 65 μm) indicate areas shown
in higher magnification below each image. Yellow
lines encircle germ cells, according to the cell borders
visualized by overexposed images (see Fig. S7 A and
B for details). A, type A spermatogonia; dashed lines,
basal laminae of tubule cross-sections; Pl and P, pre-
leptotene and pachytene spermatocytes; Sc, Sertoli
cells; St, spermatids. (Scale bar: 5 μm.) (B–D) Number of
smFISH punctate signals per cell per 1-μm section
thickness for Aldh1a1 (B), Aldh1a2 (C), and Aldh1a3
(D) mRNA, in controls or 11.6 d after first HU injection.
Error bars, mean ± SE. A, type A spermatogonia; NA,
not applicable because no pachytene spermatocytes
were present; Pl and P, preleptotene and pachytene
spermatocytes; S, spermatozoa; Sc, Sertoli cells; St,
spermatids.
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this process. By contrast, RA is likely to regulate release of sperma-
tozoa indirectly, via Sertoli cells, because spermatozoa are understood
to be transcriptionally silent (56). Given that release of spermatozoa is
the process by which spermatozoa and Sertoli cells disengage from
each other, spermatozoa may be released passively, through RA
function in Sertoli cells. It will be useful to conduct studies to de-
termine whether RA regulates each of these two postmeiotic transi-
tions directly or indirectly, by searching for RA target genes yet to
be identified.
RA Concentrations Change Periodically, as Reflected by STRA8
Expression Patterns. Recent studies have addressed the question
of whether RA levels fluctuate in the testis to regulate the 8.6-d
cycle of spermatogenesis. Insights into the question have emerged
from studies of Aldh1a gene expression, RAR receptor function,
and relative measurements of RA levels (27, 43, 57). However, the
actual concentrations of RA in testes, and their dynamics and range,
remained unclear. We previously reported that the RA-responsive
marker STRA8 is expressed periodically in the unperturbed testis,
and, on this basis, we postulated that RA levels rise and fall peri-
odically (22). By absolute quantification of RA levels, we now
provide direct evidence that RA levels change periodically and that
these changes are mirrored by changes in STRA8 expression: RA
levels are low in stages II to VI, rise in stages VII and VIII, and
remain high until stages XII/I. This long elevation of RA levels in
stages VII to XII/I is consistent with other published expression data
and functional studies (27, 42, 43). By contrast, Hogarth et al. (57)
suggested, based on relative RA measurement, a sharp peak in RA
levels in stages VIII and IX. This difference between Hogarth et al.’s
findings and those reported here likely reflects differences in ex-
perimental designs and in methods of measurement and analysis
employed. For example, while we analyzed stage-synchronized testes
between 5 and 17 d after RA injection, Hogarth et al. analyzed
testes between 42 and 50 d after RA injection, by which point
synchrony may be less consistent (41, 58).
Our findings demonstrate that, in the unperturbed testis, RA
concentrations rise in stages VII and VIII, thereby coordinating
four spermatogenic transitions, and they remain elevated until
stages XII/I. We previously showed that germ cells have stage-
limited competencies to undergo spermatogonial differentiation
and meiotic initiation (22). These windows of competence begin
while RA levels are low, and end (in stage VIII) while RA levels
are still high, so that the competencies intersect with high RA levels
briefly to confine the timing of premeiotic transitions (to stages VII
and VIII). It remains to be determined whether round spermatids
have a similarly limited competency (ending in stage VIII) to un-
dertake the initiation of spermatid elongation (in stages VII
and VIII).
Periodic RA from Sertoli Cells and Pachytene Spermatocytes Coordinates
Four Transitions. Based on the observation that an RA-synthesizing
enzyme, Aldh1a2, is expressed in pachytene spermatocytes (42, 43)
and that spermatogonial differentiation requires RA, Sugimoto
et al. (43) hypothesized that production of RA by pachytene sper-
matocytes induces the next round of spermatogonial differentiation.
Indeed, we found that RA concentrations increase when Aldh1a2-
expressing pachytene spermatocytes first appear in young males
(Fig. 5B), consistent with Sugimoto et al.’s suggestion that pachy-
tene spermatocytes produce RA. However, using genetic and
chemical cell depletion assays, we showed that RA from pachytene
spermatocytes is required for postmeiotic transitions, but not for
premeiotic transitions. Based on the findings reported here, we
propose that pre- and postmeiotic transitions are regulated by RA
from different sources. Specifically, the model posits that Sertoli
cells periodically produce RA to regulate two premeiotic transitions
and that pachytene spermatocytes produce RA to regulate two
postmeiotic transitions. Several observations support the model that
these premeiotic transitions are coordinated by RA from Sertoli
cells (but not from pachytene spermatocytes). First, Sertoli cell-
specific ablations of Aldh1a1-3 cause an arrest of the first sper-
matogonial differentiation in postnatal mice (28). Second, using RA
quantification, we now show that RA periodicity (with rising RA
concentrations in stages VII and VIII) is maintained even in the
absence of pachytene spermatocytes. Further, we provide both
chemical and genetic evidence that depletion of pachytene
spermatocytes does not affect the timing of the premeiotic
transitions: These timed transitions are maintained in Dmc1- and
Spo11-deficient males, in which pachytene spermatocytes are
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Fig. 7. RA from pachytene spermatocytes is required for postmeiotic but not
premeiotic transitions. (A and B) Percentage of testis tubule cross-sections con-
taining aligned spermatozoa (A) and step 7 and 8 spermatids (B), in controls or
11.6 d after first HU injection. HU + WIN: mice were given injections of HU and
then daily injections of WIN18,446, beginning 7.6 d after first HU injection. HU +
RA, mice received single dose of RA, 9.6 d after first HU injection. Error bars,
mean ± SD, *P < 0.01 (Tukey–Kramer test). NS, not significant (P > 0.05). (C) Per-
centage of testis tubule cross-sections containing preleptotene spermatocytes, in
controls or 11.6 d after first HU injection, and in Dmc1- or Spo11-deficient testes.
Error bars, mean ± SD, *P < 0.05, **P < 0.01 (Tukey–Kramer test). NS, not signifi-
cant (P > 0.05). (D) Immunostaining for STRA8 and KIT on control or HU-injected
testis cross-sections. Roman numerals indicate stages. Insets (14.5 μm × 14.5 μm)
enlarge boxed regions. Dashed lines, basal laminae of tubule cross-sections. Ar-
rowheads, spermatogonia (white) and preleptotene spermatocytes (yellow). (Scale
bar: 10 μm.)
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depleted. Finally, Sertoli cells establish a stage-dependent cycle
of metabolism in neonatal males, before pachytene spermato-
cytes first appear (59), leading us to propose that Sertoli cells
may produce RA periodically to coordinate the premeiotic
transitions, independent of RA from pachytene spermatocytes.
We do not yet know why the pre- and postmeiotic transitions
require different cellular sources of RA. In the seminiferous tu-
bule, premeiotic germ cells are confined to the basal compartment,
which is separated from the luminal compartment, where pachy-
tene spermatocytes and postmeiotic germ cells are located, by tight
junctions formed between Sertoli cells (60) (Fig. 8B). This basal vs.
luminal arrangement may influence the diffusion, degradation,
and availability of RA produced by Sertoli cells and pachytene
spermatocytes. However, we surmise that RA is not segregated
strictly between basal and luminal compartments. Indeed, in Ser-
toli cell-specific Aldh1a1-3–deficient testes, the resulting arrest at
the first (juvenile) spermatogonial differentiation could be rescued
by a single injection of RA, with all germ cell layers observed
subsequently, in adult testes (28). This suggests that RA from
pachytene spermatocytes can diffuse into the basal compartment
to affect the two premeiotic transitions, perhaps redundantly with
RA from Sertoli cells. Conversely, 20 wk after RA injection, Ser-
toli cell-specific Aldh1a1-3–deficient males displayed abnormalities
in release of spermatozoa (28), suggesting that Sertoli cell pro-
duction of RA may contribute, modestly, to this process. Thus,
pachytene spermatocytes may work collaboratively with Sertoli
cells to ensure high RA concentrations throughout the seminif-
erous tubules. Alternatively, the postmeiotic transitions may sim-
ply require a higher level of RA (from Sertoli cells plus pachytene
spermatocytes) than the premeiotic transitions.
In summary, we conclude that both Sertoli cells and pachytene
spermatocytes produce RA to establish a periodicity of testicular
RA levels, which coordinate the four key transitions in sper-
matogenesis in close physical and temporal proximity. Our
findings may have practical implications for in vitro spermato-
genesis. Recently, successful spermatogenesis from ES cells to
haploid spermatid-like cells was achieved by culturing within
gonadal aggregates (61). However, postmeiotic spermatogenesis
in vitro (to produce functional spermatozoa) has yet to be
achieved. Our findings that haploid spermatids require periodic
RA signals to complete spermatogenesis may help advance the
technology of in vitro gamete production.
Materials and Methods
Mice. Three types of mice were used: WT (C57BL/6NTac), Dmc1-deficient (B6.
Cg-Dmc1tm1Jcs/JcsJ) (50), and Spo11-deficient (B6-129X1 Spo11tm1Mjn) (52).
See SI Materials and Methods for strain and genotyping details. Unless
otherwise noted, experiments were performed on 6- to 8-wk-old male mice,
fed a regular (vitamin A-sufficient) diet. All experiments involving mice were
approved by the Committee on Animal Care at the Massachusetts Institute
of Technology.
Statistics. Unless otherwise noted, data are represented as mean ± SD or SE of
three or more biological replicates. When comparing two groups, the t test
(one-tailed as indicated) was employed. When comparing three or more
groups, a one-way ANOVA with the Tukey–Kramer post hoc test was used.
Histology. Testes were fixed overnight in Bouin’s solution, embedded in paraffin,
sectioned, and stained with hematoxylin and periodic acid-Schiff (PAS). All sections
were examined using a light microscope. Germ cell types were identified by their
location, nuclear size, and chromatin pattern (62). See SI Materials andMethods for
details on identification of seminiferous tubule stages.
Chemical Treatments. Mice received i.p. or s.c. injections of all-trans RA,
WIN18,446, BrdU, EdU, and/or hydroxyurea (HU). See SI Materials and
Methods for details.
Immunostaining on Testis Sections. Testes were fixed overnight in either
Bouin’s solution or 4% (wt/vol) paraformaldehyde (PFA), embedded in par-
affin, and sectioned at 5 μm thickness. Slides were dewaxed, rehydrated, and
heated in 10 mM sodium citrate buffer (pH 6.0). Sections were blocked, in-
cubated with the primary antibody, washed with PBS, and incubated with
secondary antibody. Detection was fluorescent or colorimetric. See SI Ma-
terials and Methods for details.
Nuclear Spreads of Spermatocytes. Testes were dissected to obtain single cells,
including spermatocytes, as previously described (8). Cell suspensions were
placed on slides and fixed in 1% (wt/vol) PFA. Slides were washed, air dried, and
stored at −80 °C before use. For immunostaining, slides were brought to room
temperature and washed with PBS. See SI Materials and Methods for details.
Single-Molecule Fluorescent in Situ Hybridization. Probe design, synthesis, and
coupling were as previously described (47, 63). Testes were fixed in 4% (wt/vol)
PFA and embedded in optimal cutting temperature compound (O.C.T.).
Frozen blocks were sectioned at 8 μm thickness and dehydrated overnight in
70% (vol/vol) ethanol at 4 °C. Hybridization was performed as previously
described (47, 63). Counting of individual mRNA particles, image stitching,
and data analysis were performed using custom Matlab software as pre-
viously described (47, 63). See SI Materials and Methods for details.
Absolute Quantification of RA Levels. Sample preparation and RA quantification
were performed according to a published protocol (64). Testes were collected
and homogenized by hand in ground glass homogenizers on ice in 1 mL of
saline (0.9% NaCl). All-trans RA was extracted and quantified by liquid chro-
matography/mass spectrometry. See SI Materials and Methods for details.
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Fig. 8. A proposed model by which RA coordinates
spermatogenesis. (A) Periodic RA signaling coordi-
nates four transitions. Blue, high RA concentration;
purple, spermatogonial differentiation; green, mei-
otic initiation; brown, initiation of spermatid elon-
gation; gray, release of spermatozoa. (B) Sertoli cells
express Aldh1a1 to produce RA required for sper-
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